Akso Health Group current report, Q3 FY2018

SEC Filing Summary: Hexindai Inc. (Form 6-K)

Business Context and Reporting Period

This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of July 2018. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on July 30, 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

Financial Metrics

The provided filing text contains only the cover page, signature block, and exhibit index. It does not include a press release or financial statements. Consequently, the filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics.

Material Changes

No material changes versus the prior comparable period are described in the provided text, as the document lacks operational or financial data.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. The only substantive content referenced is an Exhibit 99.1 Press Release, the text of which is not included in the input.

Key Facts for Investor Verification

  • The filing is a Form 6-K for Hexindai Inc. dated July 30, 2018.
  • The document references a Press Release (Exhibit 99.1) but does not include its content.
  • No financial data or operational updates are present in the provided text.
  • Investors must locate the full text of Exhibit 99.1 to obtain the actual news or financial results intended by this filing.